Jian Rong

Jian Rong

Auto-generated profile, based on publicly available information

Jian Rong

Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
DMDavid D. McManus
David D. McManus
JRJian Rong
Jian Rong
THTianxiao Huan
Tianxiao Huan
SLSean Lacey
Sean Lacey
KTKahraman Tanriverdi
Kahraman Tanriverdi
DLDaniel Levy
Daniel Levy
Cardiometabolic (CM) risk factors are heritable and cluster in individuals. We hypothesized that CM risk factors are associated with multiple shared and unique mRNA and microRNA (miRNA) signatures. We examined associations of mRNA and miRNA levels with 6 CM traits: body mass index, HDL-cholesterol and triglycerides, fasting glucose, and systolic and diastolic blood pressures through cross-sectional analysis of 2812 Framingham Heart Study who had whole blood collection for RNA isolation for mRNA and miRNA expression studies and who consented to genetic research. We excluded participants taking medication for hypertension, dyslipidemia, or diabetes. We measured mRNA (n = 17,318; using the Affymetrix GeneChip Human Exon 1.0 ST Array) and miRNA (n = 315; using qRT-PCR) expression in whole blood. We used linear regression for mRNA analyses and a combination of linear and logistic regression for miRNA analyses. We conducted miRNA-mRNA coexpression and gene ontology enrichment analyses to explore relations between pleiotropic miRNAs, mRNA expression, and CM trait clustering. We identified hundreds of significant associations between mRNAs, miRNAs, and individual CM traits. Four mRNAs (FAM13A, CSF2RB, HIST1H2AC, WNK1) were associated with all 6 CM traits (FDR < 0.001) and four miRNAs (miR-197-3p, miR-328, miR-505-5p, miR-145-5p) were associated with four CM traits (FDR < 0.05). Twelve mRNAs, including WNK1, that were coexpressed with the four most pleiotropic miRNAs, were also miRNA targets. mRNAs coexpressed with pleiotropic miRNAs were enriched for RNA metabolism (miR-505-5p), ubiquitin-dependent protein catabolism (miR-197-3p, miR-328) and chromatin assembly (miR-328). We identified mRNA and miRNA signatures of individual CM traits and their clustering. Implicated transcripts may play causal roles in CM risk or be downstream consequences of CM risk factors on the transcriptome. Studies are needed to establish whether or not pleiotropic circulating transcripts illuminate causal pathways for CM risk.

1 February 2021 in Hypertension
Verified
Journal Article
Open access
PDF file
LCLeroy L. Cooper
Leroy L. Cooper
JRJian Rong
Jian Rong
Niema PahlevanNiema Pahlevan
Niema Pahlevan
DRDerek Rinderknecht
Derek Rinderknecht
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin
GMGary F. Mitchell
Gary F. Mitchell
Intrinsic frequencies (IFs) derived from arterial waveforms are associated with cardiovascular performance, aging, and prevalent cardiovascular disease (CVD). However, prognostic value of these novel measures is unknown. We hypothesized that IFs are associated with incident CVD risk. Our sample was drawn from the Framingham Heart Study Original, Offspring, and Third Generation Cohorts and included participants free of CVD at baseline (N=4700; mean age 52 years, 55% women). We extracted 2 dominant frequencies directly from a series of carotid pressure waves: the IF of the coupled heart and vascular system during systole (ω 1 ) and the IF of the decoupled vasculature during diastole (ω 2 ). Total frequency variation (Δω) was defined as the difference between ω 1 and ω 2 . We used Cox proportional hazards regression models to relate IFs to incident CVD events during a mean follow-up of 10.6 years. In multivariable models adjusted for CVD risk factors, higher ω 1 (hazard ratio [HR], 1.14 [95% CI], 1.03–1.26]; P =0.01) and Δω (HR, 1.16 [95% CI, 1.03–1.30]; P =0.02) but lower ω 2 (HR, 0.87 [95% CI, 0.77–0.99]; P =0.03) were associated with higher risk for incident composite CVD events. In similarly adjusted models, higher ω 1 (HR, 1.23 [95% CI, 1.07–1.42]; P =0.004) and Δω (HR, 1.26 [95% CI, 1.05–1.50]; P =0.01) but lower ω 2 (HR, 0.81 [95% CI, 0.66–0.99]; P =0.04) were associated with higher risk for incident heart failure. IFs were not significantly associated with incident myocardial infarction or stroke. Novel IFs may represent valuable markers of heart failure risk in the community.

8 April 2024 in JMIR Cardio
Verified
Journal Article
Open access
XWXuzhi Wang
Xuzhi Wang
YZYuankai Zhang
Yuankai Zhang
CPChathurangi H Pathiravasan
Chathurangi H Pathiravasan
NUNene C Ukonu
Nene C Ukonu
JRJian Rong
Jian Rong
GMGary F Mitchell
Gary F Mitchell
Background: Short-term blood pressure variability (BPV) is associated with arterial stiffness in patients with hypertension. Few studies have examined associations between arterial stiffness and digital home BPV over a mid- to long-term time span, irrespective of underlying hypertension. Objective: This study aims to investigate if arterial stiffness traits were associated with subsequent mid- to long-term home BPV in the electronic Framingham Heart Study (eFHS). We hypothesized that higher arterial stiffness was associated with higher home BPV over up to 1-year follow-up. Methods: At a Framingham Heart Study research examination (2016-2019), participants underwent arterial tonometry to acquire measures of arterial stiffness (carotid-femoral pulse wave velocity [CFPWV]; forward pressure wave amplitude [FWA]) and wave reflection (reflection coefficient [RC]). Participants who agreed to enroll in eFHS were provided with a digital blood pressure (BP) cuff to measure home BP weekly over up to 1-year follow-up. Participants with less than 3 weeks of BP readings were excluded. Linear regression models were used to examine associations of arterial measures with average real variability (ARV) of week-to-week home systolic (SBP) and diastolic (DBP) BP adjusting for important covariates. We obtained ARV as an average of the absolute differences of consecutive home BP measurements. ARV considers not only the dispersion of the BP readings around the mean but also the order of BP readings. In addition, ARV is more sensitive to measurement-to-measurement BPV compared with traditional BPV measures. Results: Among 857 eFHS participants (mean age 54, SD 9 years; 508/857, 59% women; mean SBP/DBP 119/76 mm Hg; 405/857, 47% hypertension), 1 SD increment in FWA was associated with 0.16 (95% CI 0.09-0.23) SD increments in ARV of home SBP and 0.08 (95% CI 0.01-0.15) SD increments in ARV of home DBP; 1 SD increment in RC was associated with 0.14 (95% CI 0.07-0.22) SD increments in ARV of home SBP and 0.11 (95% CI 0.04-0.19) SD increments in ARV of home DBP. After adjusting for important covariates, there was no significant association between CFPWV and ARV of home SBP, and similarly, no significant association existed between CFPWV and ARV of home DBP (P>.05). Conclusions: In eFHS, higher FWA and RC were associated with higher mid- to long-term ARV of week-to-week home SBP and DBP over 1-year follow-up in individuals across the BP spectrum. Our findings suggest that higher aortic stiffness and wave reflection are associated with higher week-to-week variation of BP in a home-based setting over a mid- to long-term time span.

31 December 2024 in JMIR Aging
Verified
Journal Article
Open access
JRJian Rong
Jian Rong
CPChathurangi H Pathiravasan
Chathurangi H Pathiravasan
YZYuankai Zhang
Yuankai Zhang
JFJamie Faro
Jamie Faro
XWXuzhi Wang
Xuzhi Wang
JMJoanne Murabito, Murabito
Joanne Murabito, Murabito
Background: Smartphone apps can be used to monitor chronic conditions and offer opportunities for self-assessment conveniently at home. However, few digital studies include older adults. Objective: We aim to describe a new electronic cohort of older adults embedded in the Framingham Heart Study including baseline smartphone survey return rates and survey completion rates by smartphone type (iPhone [Apple Inc] and Android [Google LLC] users). We also aim to report survey results for selected baseline surveys and participant experience with this study’s app. Methods: Framingham Heart Study Offspring and Omni (multiethnic cohort) participants who owned a smartphone were invited to download this study’s app that contained a range of survey types to report on different aspects of health including self-reported measures from the Patient-Reported Outcomes Measurement Information System (PROMIS). iPhone users also completed 4 tasks including 2 cognitive and 2 physical function testing tasks. Baseline survey return and completion rates were calculated for 12 surveys and compared between iPhone and Android users. We calculated standardized scores for the PROMIS surveys. The Mobile App Rating Scale (MARS) was deployed 30 days after enrollment to obtain participant feedback on app functionality and aesthetics. Results: We enrolled 611 smartphone users (average age 73.6, SD 6.3 y; n=346, 56.6% women; n=88, 14.4% Omni participants; 478, 78.2% iPhone users) and 596 (97.5%) returned at least 1 baseline survey. iPhone users had higher app survey return rates than Android users for each survey (range 85.5% to 98.3% vs 73.8% to 95.2%, respectively), but survey completion rates did not differ in the 2 smartphone groups. The return rate for the 4 iPhone tasks ranged from 80.9% (380/470) for the gait task to 88.9% (418/470) for the Trail Making Test task. The Electronic Framingham Heart Study participants had better standardized t scores in 6 of 7 PROMIS surveys compared to the general population mean (t score=50) including higher cognitive function (n=55.6) and lower fatigue (n=45.5). Among 469 participants who returned the MARS survey, app functionality and aesthetics was rated high (total MARS score=8.6 on a 1‐10 scale). Conclusions: We effectively engaged community-dwelling older adults to use a smartphone app designed to collect health information relevant to older adults. High app survey return rates and very high app survey completion rates were observed along with high participant rating of this study’s app.

10 October 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YZYuankai Zhang
Yuankai Zhang
JRJian Rong
Jian Rong
XWXuzhi Wang
Xuzhi Wang
ESEric Schramm
Eric Schramm
CPChathurangi H Pathiravasan
Chathurangi H Pathiravasan
JMJoanne Murabito, Murabito
Joanne Murabito, Murabito
Background: Survey fatigue is a common challenge in longitudinal studies, particularly when using smartphone apps to collect survey data. Evidence-based strategies are needed to maintain longitudinal response rates. Objective: This study aims to evaluate the effect of a more frequent smartphone-administered survey deployment strategy with smaller survey batches on participant response rates over an extended period. Methods: We conducted a randomized controlled trial (NCT04752657) embedded in the electronic Framingham Heart Study cohorts between June 2021 and December 2023. Participants were randomly allocated to receive a full set of surveys every 4 weeks (control group) or half of the survey set biweekly, such that the full set is completed every 4 weeks (experimental group). Randomization was stratified by age (≤75 y vs >75 y) and phone type (Android vs iPhone). Married couples were assigned to the same group using a blocked randomization approach. The primary outcome was the proportion of surveys returned per participant assessed longitudinally across four periods (baseline to wk 8, wk 8-16, wk 16-24, and wk 24-32), with 19, 17, 16, and 15 unique surveys deployed, respectively. We used mixed-effects regression models with random intercepts to compare the repeated outcome between groups. Stratified analyses by age and sex were performed. Results: Among 492 participants (mean age 74, SD 6.3 y; 58%, n=284 women, 84%, n=413 non-Hispanic White), there was evidence that the experimental group had higher response rates over time compared to the control group (P=.003 for interaction between deployment pattern and time). Both groups showed similar proportions of surveys returned during the first period (75% vs 76%). The experimental group had higher response rates than the control group in subsequent periods (70% vs 67% in wk 8-16, 64% vs 59% in wk 16-24, and 58% vs 50% in wk 24-32). The proportion of participants not returning any surveys increased from 3% to 38% in the control group compared to 1% to 28% in the experimental group across the four time periods. Stratified analyses revealed that among younger participants (≤75 y), the experimental group showed 12% higher survey response rates compared to the control group in the final period, while the difference was minimal among older participants (>75 years). The effect of the deployment pattern was similar for men and women. Three-way interaction analyses revealed no significant differences in the deployment pattern effect over time by age group (P=.95) or sex (P=.65). Conclusions: Administering half of the surveys every 2 weeks, as compared to all surveys every 4 weeks, was associated with higher maintained longitudinal survey response rates. This strategy may help mitigate survey fatigue and improve data quality in digital health studies. Trial Registration: ClinicalTrials.gov NCT04752657; https://clinicaltrials.gov/study/NCT04752657

11 February 2020 in medRxiv
Verified
Preprint
Open access
PDF file
Joonatan PalmuJoonatan Palmu
Joonatan Palmu
JWJeramie D. Watrous
Jeramie D. Watrous
KMKysha Mercader
Kysha Mercader
AHAki S. Havulinna
Aki S. Havulinna
KLKim A. Lagerborg
Kim A. Lagerborg
TNTeemu Niiranen
Teemu Niiranen
Epidemiological and animal studies have associated systemic inflammation with blood pressure (BP). However, the mechanistic factors linking inflammation and BP remain unknown. Fatty acid derived eicosanoids serve as mediators of inflammation and have been suggested to also regulate renal vascular tone, peripheral resistance, renin-angiotensin system, and endothelial function. We therefore hypothesize that specific pro- and anti-inflammatory eicosanoids are linked with BP. We studied a population sample of 8099 FINRISK 2002 participants randomly drawn from the Finnish population register (53% women, mean age 48±13 years) and, for external validation, a sample of 2859 Framingham Heart Study (FHS) Offspring study participants (55% women, mean age 66±9 years). Using non-targeted liquid chromatography-mass spectrometry, we profiled 545 distinct high-quality eicosanoids and related oxylipin mediators in plasma. Adjusting for conventional hypertension risk factors, we observed 187 (34%) metabolites that were significantly associated with systolic BP ( P < Bonferroni-corrected threshold of 0.05/545). We used forward selection linear regression modeling in FINRISK to define a general formula for individual eicosanoid risk score. Individuals of the top risk score quartile in FINRISK had a 9.0 mmHg (95% CI 8.0-10.1) higher systolic BP compared with individuals in the lowest quartile in fully adjusted models. Observed metabolite associations were consistent across FINRISK and FHS. In conclusion, plasma eicosanoids demonstrate strong associations with BP in the general population. As eicosanoid compounds affect numerous physiological processes that are central to BP regulation, they may offer new insights regarding pathogenesis of hypertension, as well as serve as potential targets for therapeutic intervention.